Decuprate: Phase II started

Wilson began the open-label, international Phase II WTX101-201 trial to evaluate 30-150 mg oral WTX101 plus omeprazole for 24 weeks in up to 30 newly diagnosed patients. WTX101 has Orphan Drug designa...